HCP
PODD icon

Hexagon Capital Partners’s Insulet PODD Stock Holding History

Hexagon Capital Partners’s Portfolio PODD Stock Details PODD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-58
Closed -$12.6K – 1512
2023
Q4 		$12.6K Buy
+58
New +$9.95K ﹤0.01% 768

Other funds holding PODD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Hexagon Capital Partners's PODD Position: Q1 2024 in Review

Hexagon Capital Partners sold out of Insulet (PODD) in Q1 2024, closing a stake of 58 shares — an estimated $12.6K sold.

Hexagon Capital Partners first reported a position in PODD in Q4 2023 and held it in 1 quarter. The position peaked at $12.6K in Q4 2023. 563 funds tracked by Wall St. Rank hold PODD as of Q1 2024.

  • Hexagon Capital Partners reported no remaining Insulet position as of Q1 2024 after selling out during the quarter.
  • Hexagon Capital Partners sold 58 Insulet shares in Q1 2024, an estimated $12.6K.
  • Hexagon Capital Partners first reported a position in Insulet in Q4 2023 and held it in 1 quarter.
  • Hexagon Capital Partners's Insulet position peaked at $12.6K in Q4 2023.
  • 563 funds tracked by Wall St. Rank held Insulet as of Q1 2024.

Based on Hexagon Capital Partners's 13F filing for Q1 2024, filed 18 Apr 2024.